Equivalents of the neutrophil-to-lymphocyte ratio of circulating pool of stem and immature hematopoietic cells for assessing liver transplant status

IF 0.2 Q4 TRANSPLANTATION
A. N. Shutko, O. A. Gerasimova, N. V. Marchenko, I. I. Tileubergenov
{"title":"Equivalents of the neutrophil-to-lymphocyte ratio of circulating pool of stem and immature hematopoietic cells for assessing liver transplant status","authors":"A. N. Shutko, O. A. Gerasimova, N. V. Marchenko, I. I. Tileubergenov","doi":"10.15825/1995-1191-2023-3-97-105","DOIUrl":null,"url":null,"abstract":"Objective : to study the applicability of the neutrophil-to-lymphocyte ratio (NLR) for monitoring recipient status and for possible minimization of maintenance immunosuppression in the long-term period after liver transplantation (LT). Materials and methods . Blood samples of 19 recipients with satisfactory graft function were examined by flow cytofluorometry at various time periods after LT using hematopoietic stem cell markers CD133, their CD31 derivatives, and alpha-fetoprotein (AFP), compared with the conventional NLR. Results . The use of NLR equivalents with CD133 and CD31 to assess liver transplant status is due to their high representation in liver tissue. Their values change in the long-term posttransplant period (from 1.5 to 6–7 years following LT) ≈20-fold and in different directions, but only when measuring their commissural to the liver cell fractions bearing the AFP marker. Conclusion . In contrast to the conventional NLR, maintenance of the lowest level of CD31 AFP, an NLR «equivalent», achieved at 1.5 years after LT, can be considered a criterion for the success of immunosuppressive therapy in the long-term post-LT period. The developed technique can be used to decide on whether to reduce or discontinue medication-assisted prophylaxis of graft rejection.","PeriodicalId":43091,"journal":{"name":"Vestnik Transplantologii i Iskusstvennyh Organov","volume":"16 1","pages":"0"},"PeriodicalIF":0.2000,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vestnik Transplantologii i Iskusstvennyh Organov","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15825/1995-1191-2023-3-97-105","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Objective : to study the applicability of the neutrophil-to-lymphocyte ratio (NLR) for monitoring recipient status and for possible minimization of maintenance immunosuppression in the long-term period after liver transplantation (LT). Materials and methods . Blood samples of 19 recipients with satisfactory graft function were examined by flow cytofluorometry at various time periods after LT using hematopoietic stem cell markers CD133, their CD31 derivatives, and alpha-fetoprotein (AFP), compared with the conventional NLR. Results . The use of NLR equivalents with CD133 and CD31 to assess liver transplant status is due to their high representation in liver tissue. Their values change in the long-term posttransplant period (from 1.5 to 6–7 years following LT) ≈20-fold and in different directions, but only when measuring their commissural to the liver cell fractions bearing the AFP marker. Conclusion . In contrast to the conventional NLR, maintenance of the lowest level of CD31 AFP, an NLR «equivalent», achieved at 1.5 years after LT, can be considered a criterion for the success of immunosuppressive therapy in the long-term post-LT period. The developed technique can be used to decide on whether to reduce or discontinue medication-assisted prophylaxis of graft rejection.
造血干细胞和未成熟造血细胞循环池中中性粒细胞与淋巴细胞比值的当量,用于评估肝移植状态
目的:研究中性粒细胞与淋巴细胞比值(NLR)在肝移植术后长期监测受体状态和尽可能减少维持性免疫抑制的适用性。材料和方法。19例移植功能满意的受者的血液样本在移植后不同时期用造血干细胞标记物CD133及其CD31衍生物和甲胎蛋白(AFP)进行了流式细胞荧光测定,并与传统NLR进行了比较。结果。使用NLR与CD133和CD31等同物来评估肝移植状态是由于它们在肝组织中的高代表性。它们的值在移植后的长期(从移植后1.5年到移植后6-7年)≈20倍,并且在不同的方向上发生变化,但仅在测量它们与带有AFP标记的肝细胞组分的相互关系时才会发生变化。结论。与传统NLR相比,在LT后1.5年维持最低水平的CD31 AFP (NLR“等效”)可以被认为是LT后长期免疫抑制治疗成功的标准。该技术可用于决定是否减少或停止药物辅助预防移植排斥反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.70
自引率
50.00%
发文量
46
审稿时长
12 weeks
期刊介绍: Organ transplantation is one of the most challenging and complex areas of modern medicine, based on a rapid development of innovative technologies in surgery, anesthesiology and intensive care, cardiovascular surgery, immunology, molecular biology, biotechnology, and natural sciences. Regenerative medicine and the development of artificial and bioartificial organs and systems are the key issues for further progress in transplantation. Cardiology, nephrology, hepatology, endocrinology, and many other medical areas constitute the basis of clinical transplantation. Organization and coordination of organ donation present a serious challenge on a state level requiring cooperation and active work of various health authorities. The development of clinical transplantation in Russia has led to the formation of a wide network of transplant centers. Hundreds of hearts, kidneys, livers, lungs, and pancreases transplantations perform annually. Improvement of transplant availability for patients and an increased number of professionals involved in the transplantation process are the contemporary realities in the Russian Federation. Thus, the journal aims to serve as a forum for an exchange of research information, clinical expertise, current trends and the recent developments in the field of transplantation and organ donation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信